Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Galapagos Signs With EPA And Ono
April 23, 2007
| A version of this story appeared in
Volume 85, Issue 17
Galapagos' BioFocus DPI service division has agreed to procure and manage small-molecule compounds for EPA's ToxCast program for the prioritization of environmentally relevant compounds. The five-year contract is valued at up to $6.3 million. BioFocus will create the library at its South San Francisco site, where it also houses a small-molecule repository for NIH's Roadmap initiative. Separately, BioFocus has signed compound supply and medicinal and computational chemistry agreements with Tokyo-based Ono Pharmaceutical. The deals build on a collaboration that began in 2004.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter